KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Change in Cash: 2009-2025

Historic Change in Cash for Rigel Pharmaceuticals (RIGL) over the last 15 years, with Sep 2025 value amounting to -$4.9 million.

  • Rigel Pharmaceuticals' Change in Cash fell 131.16% to -$4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year decrease of 149.39%. This contributed to the annual value of $24.0 million for FY2024, which is 187.74% up from last year.
  • Latest data reveals that Rigel Pharmaceuticals reported Change in Cash of -$4.9 million as of Q3 2025, which was down 163.46% from $7.7 million recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Change in Cash ranged from a high of $64.8 million in Q2 2021 and a low of -$54.4 million during Q3 2021.
  • Its 3-year average for Change in Cash is $2.2 million, with a median of $5.1 million in 2024.
  • Examining YoY changes over the last 5 years, Rigel Pharmaceuticals' Change in Cash showed a top increase of 839.79% in 2021 and a maximum decrease of 55,630.61% in 2021.
  • Over the past 5 years, Rigel Pharmaceuticals' Change in Cash (Quarterly) stood at -$11.5 million in 2021, then soared by 53.04% to -$5.4 million in 2022, then plummeted by 133.55% to -$12.6 million in 2023, then soared by 140.02% to $5.1 million in 2024, then tumbled by 131.16% to -$4.9 million in 2025.
  • Its Change in Cash stands at -$4.9 million for Q3 2025, versus $7.7 million for Q2 2025 and -$11.0 million for Q1 2025.